H.C. Wainwright Starts Rapport Therapeutics (RAPP) at Buy
Tweet
Share
E-mailGet Alerts RAPP Hot Sheet
Price: $48.42 --0%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao initiates coverage on Rapport Therapeutics (NASDAQ: RAPP) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Rapport Therapeutics click here. For more ratings news on Rapport Therapeutics click here.
Shares of Rapport Therapeutics closed at $14.43 yesterday.
You May Also Be Interested In
- Rapport Therapeutics (RAPP) PT Raised to $75 at Raymond James
- CLSA Starts Astellas Pharma Inc (4503:JP) (ALPMY) at Outperform (2)
- Cannonball Research Starts Zapata Computing (ZPTA) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
